Purpose: To evaluate the efficacy, safety, and outcomes of a blade- and cautery-free surgical protocol for pterygium removal.
Methods: Pterygium removal surgery was done in 69 eyes (67 patients; 24 males and 43 females) who were followed up for at least 6 months. The surgery was characterized by blunt separation of the pterygium from the head to the limbal arc using the tip of Vannas scissors and modified procedures, such as transpositional flapping and suture closure. Neither a blade nor a cautery was used.
Results: The reported subjects were 60.7 years old on average, and most of them had primary pterygium (66 out of 69). The proposed surgical protocol was simple to perform, requiring an average operation time of 18.7 min which was shorter than that of the suture and fibrin glue groups mentioned in relevant reports. Post-anesthesia pain was relieved quickly 1 day after surgery without the use of pain killers. During the follow-up period of 11.3 ± 3.1 months, recurrence of pterygium requiring additional surgery was seen in only three eyes (4.3%).
Conclusion: The potential of the examined protocol as an easy, efficient, and reliable approach was demonstrated.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11887476 | PMC |
http://dx.doi.org/10.3389/fmed.2025.1522167 | DOI Listing |
Front Med (Lausanne)
February 2025
Affiliated Eye Hospital of Nanjing Medical University, Nanjing, China.
Purpose: To evaluate the efficacy, safety, and outcomes of a blade- and cautery-free surgical protocol for pterygium removal.
Methods: Pterygium removal surgery was done in 69 eyes (67 patients; 24 males and 43 females) who were followed up for at least 6 months. The surgery was characterized by blunt separation of the pterygium from the head to the limbal arc using the tip of Vannas scissors and modified procedures, such as transpositional flapping and suture closure.
Sci Rep
February 2025
Department of Ophthalmology, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, No.201-209, Hubinan Road, Siming District, Xiamen, 361000, Fujian, China.
Pterygium is considered as important clinical problem due to its special characteristics such as high incidence, multi-factorial disorder and high recurrence rate. The purpose of this study is to identify the postoperative recurrence rate of pterygium and examine the association between systemic inflammation and the type of pterygium and pterygium recurrence. From January 2017 to January 2018, a total of 196 pterygium patients who received surgery were included in this study.
View Article and Find Full Text PDFAm J Ophthalmol
February 2025
Bascom Palmer Eye Institute, University of Miami Miller School of Medicine. Electronic address:
Purpose: To develop and validate a deep learning (DL) model to differentiate ocular surface squamous neoplasia (OSSN) from pterygium and pinguecula using high resolution anterior segment optical coherence tomography (AS-OCT).
Design: Retrospective Diagnostic Accuracy Study METHODS: xxx.
Setting: Single Center STUDY POPULATION: All eyes with a clinical or biopsy-proven diagnosis of OSSN, pterygium, or pinguecula that received AS-OCT imaging.
BMC Ophthalmol
December 2024
Department of Ophthalmology, Ziyang Central Hospital, Sichuan, 641300, China.
Objective: To explore the clinical efficacy of modified limbal stem cell transplantation(Modified LSC transplantation) and bandage contact lens(BCL) implantation in pterygium surgery.
Methods: A total of 479 patients with primary pterygium who were admitted to our hospital from March 2019 to March 2023 were randomly divided into three groups: the normal group (Group A: 89 patients), the control group (Group B: 195 patients), and the modified group (Group C: 195 patients). Each group received different intervention measures.
Cornea
October 2024
Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, ON, Canada.
Purpose: Ocular surface disorders (OSDs) can severely affect vision and quality of life. Autologous blood products, such as plasma rich in growth factors (PRGF), are recently available to treat OSDs refractory to traditional therapies. This review aims to summarize the efficacy and safety of PRGF in OSDs.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!